What's New at Medtronic Diabetes With Bob Vigersky, MD

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with Bob Vigersky, MD, Chief Medical Officer of Medtronic Diabetes, to discuss major developments in diabetes technology, regulatory approvals, and the company’s future direction.00:00:00 Introduction00:00:27 Background of Bob Vigersky, MD00:02:40 Updates from Medtronic Diabetes00:08:02 The Instinct Sensor00:10:20 Calibrating New Devices00:12:27 Moving to Type 200:15:00 Bolusing with New Devices00:17:39 Looking Down the Pipeline00:22:07 Prescribing the MiniMed00:35:45 Outro

Episode metadata supplied by the publisher feed · Published Oct 2, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

What's New at Medtronic Diabetes With Bob Vigersky, MD

0:00 36:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 36 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on October 2, 2025.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!